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ABSTRACT 
 The Hybrid Norwood procedure has emerged as a promising alternative palliative first 
stage treatment for infants with Hypoplastic Left Heart Syndrome (HLHS). The procedure is done 
to provide necessary blood flow to the pulmonary and systemic regions of the body. The procedure 
can affect hemodynamic conditions to be pro-thrombotic, and thrombus particles can form and 
release from the vessel walls and enter the flow. Assuming these particles are formed and released 
from the shunt surface, a Computational Fluid Dynamics (CFD) model can be used to mimic the 
patient’s vasculature geometry and predict the occurrence of embolization to the carotid or 
coronary arteries, as well as the other major arteries surrounding the heart. This study used a time 
dependent, multi-scale CFD analysis on patient-specific geometry to determine the statistical 
probability of thrombus particles exiting each major artery. The geometries explored were of a 
nominal and patient specific nature. Cases of 90% and 0% stenosis at the aortic arch were analyzed, 
including shunt diameters of 3mm, 3.5mm, and 4mm. Three different placements of the shunt were 
explored as well. The intent of this study was to suggest best methods of surgical planning in the 
Hybrid Norwood procedure by providing supporting data for optimal stroke and myocardial 
infarction prevention. 
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CHAPTER ONE: INTRODUCTION 
Hypoplastic Left Heart Syndrome (HLHS) is a congenital heart disease marked by several 
myocardial growth defects, including severe underdevelopment of the left ventricle. These 
malformations greatly affect normal blood flow through the heart as well as to the rest of the body. 
The Hybrid Norwood procedure has proven to be a viable option to treat newborns by a sequence 
of surgeries aimed at redirecting most of the workload onto the right ventricle while 
simultaneously relieving the right ventricle of pulmonary circulation. The addition of a shunt 
sutured at the top of the artificial aortic arch that releases flow at the root of the innominate artery 
reinstates blood flow to the cerebral and brachial arteries in case of severe distal aortic arch 
stenosis. 
 
Figure 1: Hybrid Norwood Stage 1 Geometry (Nationwide Children’s) 
Over the past seventeen years, the hybrid procedure has often been a preferred method to 
stage I palliation. Its results in survival can be equivalent to that of stage I palliation, and similar 
to conventional palliation. The subsequent growth of the pulmonary arch along with its 
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hemodynamic environment are comparable to pre-stage II. Ventricular function is also well 
preserved with hybrid palliation. The method requires less resources and postoperative recovery 
is relatively shortened. The goal of the Hybrid Norwood procedure is to create unhindered 
pulmonary flow, systemic flow, and intra-atrial communication. By placing bilateral pulmonary 
artery bands and a ductal stent, this outcome is possible (Honjo and Caldarone 103). 
 The conventional method was first proposed and implemented by Dr. William Norwood, 
but the hybrid method was unavailable until stenting was clinically possible. In the early 1990s, 
animal studies suggested success of using stents, and by 2002, Akintuerk et al. performed the first 
reported success of the hybrid method in which 87.5% of patients resulted positively (Honjo and 
Caldarone 104) (Akintuerk et al. 1101). This method is not a permanent solution, but rather a 
temporary palliation until the final two stages are performed. The procedure is not completely 
effective for all patients, with average results of 80% positive (Ruiz et al. 1605). 
 The procedure for the Hybrid Norwood surgery involves several steps. 
Polytetrafluoroethylene banding is applied to each branch of the pulmonary artery in order to 
balance systemic and pulmonary flow. Usually, echocardiography is used to measure the tightness 
of the bands, to ensure a specific value. These bands are to reduce flow through the pulmonary 
arteries and balance flow to the rest of the body.  A stent is then placed in the ductus arteriosus to 
allow systemic flow. Balloon atrial septostomy is then performed to open the septum between the 
atria, allowing non-oxygenated blood to mix with oxygenated blood (Brescia et al. 1778). In cases 
where there is no atrial septal defect, this concludes stage I. After recovery, the patient would then 
undergo stage II at 4 to 6 months and stage III, or Fontan procedure, at age 2. Stage II includes 
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removal of the ductus arteriosus stent and pulmonary artery bands, joining of the aorta with the 
pulmonary root, and connection of the superior vena cava to the pulmonary artery. Stage III 
includes rerouting the inferior vena cava to the pulmonary artery (Nationwidechildrens). These 
stages are separated at specific ages due to the conditions of arterial resistance that would hinder 
the desired blood flow. However, during stage I, patients presenting with restricted prograde aortic 
flow or aortic atresia will often receive a Reverse Blalock-Taussig shunt (RBTS), sutured from the 
pulmonary artery to the innominate artery. The shunt is made of polytetrafluoroethylene and is 
usually 3.5mm or 4mm in diameter, though in some cases a 3mm shunt can be used (Honjo and 
Caldarone 105). It is at this stage that this paper will focus on the hemodynamic conditions of the 
resulting stage I Hybrid Norwood with RBTS geometry. 
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CHAPTER TWO: THROMBOSIS IN RBTS CAUSING STROKE 
INCIDENCE 
The Hybrid Norwood procedure presents major complications for the patient. Mainly, the 
subsequent mixture of oxygenated and non-oxygenated blood strains the body, causing weakness 
and other physiological consequences. At the hemodynamic level, flow conditions including 
recirculation and stagnation caused by the artificial geometry paired with blood to shunt interaction 
can induce thrombosis. Thrombi particles released from the shunt location are free to travel 
through any of the major arteries, threatening stroke or myocardial infarction. 
Along with the detailed consideration of rerouting blood flow correctly during these 
procedures, an obvious concern for thrombosis arises. Specifically, in the location of the RBTS, 
thrombosis can occur and present complications. Acute occlusion of the shunt can cause 
insufficient systemic flow, requiring stenting or thrombolytic therapy. With no consistent method 
for preventing thrombosis in the shunt, many clinicians administer doses of heparin during the use 
of the RBTS (Monagle 18). 
 There are several reasons for thrombosis occurring at the shunt. According to Chesnutt, 
specific levels of shear stress in blood can promote platelet aggregation (Chesnutt and Han 12). 
Low velocity or stagnation is also an initiator of thrombosis, as activated platelets are more likely 
to adhere. At the vessel wall, the flow is the lowest. Lined with endothelial cells and a plasma 
layer, blood vessels have natural thrombosis inhibiting factors (Shadden and Hendabadi 473). A 
RBTS lacks these factors and creates a higher risk of thrombosis. 
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 Hemodynamic factors are not the only initiators of thrombosis. Foreign surfaces can 
promote thrombosis by activating the intrinsic pathway (May, Frauke, et al. 769). A study by Chan 
et al. focused on primary patency of polytetrafluoroethylene stents for treatment of venous outflow 
stenosis. The study found that thrombosis occurred highly on non-heparin-coated stents, having 
failure in less than six months. Heparin-coated stents proved to eliminate this issue (Chan et al. 
652). This requires awareness that thrombosis is not only due to hemodynamic conditions, but due 
to foreign material as well, specifically polytetrafluoroethylene. 
 As thrombosis is a concern for the RBTS, one major consideration for surgical planning is 
the location of anastomosis. In the case of the Hybrid Norwood procedure mentioned earlier, the 
distal end of the shunt is sutured to the innominate artery. This opens to the common carotid artery. 
A danger presents itself when a possible thrombus breaks free from the shunt and embolizes to the 
right carotid artery, causing stroke. If thrombi were to move proximally in the ascending aorta, 
particles could embolize to the coronary arteries, causing myocardial infarction. These cases are a 
danger to the patient’s life, and this paper seeks to understand the likelihood of possible thrombus 
embolization to specific arteries. 
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CHAPTER THREE: PREVIOUS WORK 
Our lab group has explored the problem of thrombosis in the surrounding vasculature of 
the heart. As a bridge to heart transplant, mechanical assist from a Left Ventricular Assist Device 
(LVAD) is used in patients with failing hearts. The design of the LVAD routes blood from the left 
ventricle to a pump, either continuous or pulsatile, pumping blood to the ascending aorta. 
Thrombogenic scenarios can abound in these patients due to blood-to-foreign material contact and 
abnormal hemodynamic conditions of stagnation or high vorticity. As the outlet of the LVAD is 
sutured proximal to the cerebral vessels, thrombi can travel to the carotid and vertebral arteries 
and embolize. The study of our lab group was to assess by CFD which angle of anastomosis was 
more favorable to prevent stroke incidence. It was found that a suture of 60 degrees measured from 
normal to the aorta produced the most favorable results, as opposed to 30 degrees and normal 
(Osorio 636). Furthermore, another study by our lab group performed by Prather focused on the 
angle of anastomosis optimization under pulsatile flow. The results found that normal anastomosis 
as opposed to angled geometry was optimal for reducing cerebral artery embolization (Prather 51). 
These findings influence the models explored in this paper, proposing an optimal anastomosis 
angle exists for the case of a RBTS shunt. 
The Hybrid Norwood case has also been studied and modeled by our lab group using CFD. 
Blood delivery was the focus of the study, determining a specific RBTS diameter optimal for ideal 
flow to the upper arteries. The development of such a model began with understanding the post-
operative anatomy of the major arteries in the Hybrid Norwood case. A nominal model was 
generated using generalized geometry based on clinical data. Three separate models included a 
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RBTS of 3mm, 3.5mm, and 4mm in diameter. The nominal geometry can be seen below. Note the 
nominal model does include 90% aortic arch stenosis. 
 
Figure 2: Nominal Anatomy Without RBTS (Left) and With RBTS (Right) (Ceballos 15) 
The named outlets of the major arteries are as follows: RCA is the right carotid artery; LCA 
is the left carotid artery; LSA is the left subclavian artery; LPA is the left pulmonary artery; DA is 
the descending aorta; LcorA is the left coronary artery; RcorA is the right coronary artery; RPA is 
the right pulmonary artery; and RSA is the right subclavian artery. These abbreviations will be 
used moving forward to denote the outlets of the CFD model. This nominal model was developed 
to validate a patient specific model. The patient specific geometry was fabricated by compiling CT 
scans from a patient after stage I Hybrid Norwood and modeled using Mimics. Using 3-matic to 
add the RBTS of each diameter, the patient specific model was completed and can be seen below. 
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Figure 3: Patient Specific Anatomy With RBTS 
 The two models are comparable in scale. As each model only accounts for the geometry of 
the major arteries surrounding the heart, the remainder of the pulmonary and systemic flow must 
be accounted for to provide realistic flow fields. The solution to this was to create a Lumped 
Parameter Model (LPM) that treated each area in the pulmonary and systemic blood flow as 
elements of resistance, inductance, and capacitance relating to viscous drag, flow inertia, and 
vessel compliance, respectively. Diodes were comparable to the tricuspid and pulmonary valves. 
The resulting LPM is shown in figure 4. 
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Figure 4: LPM Schematic Including RBTS (Ceballos 23) 
 Two governing differential equations are used for each R-L-C component: 
𝛥𝑝 = 𝐿
𝑑𝑄
𝑑𝑡
+ 𝑅𝑄 ( 1 ) 
𝑄 = 𝐶
𝑑(𝛥𝑝)
𝑑𝑡
   ( 2 ) 
where Δp is the pressure difference, Q is the flow rate, and t is time. Data from literature 
was collected to set a baseline for the values of R, L, and C. An iterative process was then used to 
modify these values until waveforms converged to match catheter data from literature. The right 
ventricle was modeled as a time dependent, pulsatile capacitor to drive the circuit. The resulting 
LPM consists of a 32-state variable closed loop circuit, solving ordinary differential equations 
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using a 4th order adaptive Ruge-Kutta solver (Ceballos 20-22). The solved values for R, L, and C 
are then held constant for use in all models employed in this study. 
 The LPM and CFD model is then coupled by first tuning the circuit to converge 
flow and pressures to match catheter data from literature, loading boundary conditions to the CFD 
model, running the CFD model to develop a flow field, updating the CFD boundaries in the circuit 
to equal the boundaries developed from running the CFD, running the LPM to integrate 
recalculated flow splits to the CFD model, and finally iterating to convergence the system of 
equations. Upon every iteration, flow rates change within the model. To standardize this procedure, 
convergence was defined when all changes in flow rates were less than 0.1 ml/min, requiring 
between 15 and 20 iterations in most cases. This iterative process is controlled through Star-CCM+ 
using a Java routine. This controls output of data from Star-CCM+, runs C-code to update 
boundary conditions towards convergence, loads updated data to Star-CCM+, and iterates the 
simulation. This loop is repeated until convergence is achieved (Ceballos 64). This process of 
convergence is used with 10 iterations per model discussed in the next chapter. 
 
Figure 5: Schematic of Iterative Scheme (Ceballos 65) 
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CHAPTER FOUR: METHODS 
The multiscale models were developed in Star-CCM+. The goal was to understand how 
manipulating the geometry of the RBTS would affect embolization rates. Models to observe were 
patient specific 0% and 90% aortic arch stenosis with 3mm, 3.5mm, and 4mm diameter shunts 
each, a nominal model with 90% aortic arch stenosis and shunt diameter of 3.5mm, and three 
alternate orientation options of the RBTS with 3.5mm diameter under 0% aortic arch stenosis case. 
As results began to populate from the first six simulations, a 3.5mm shunt seemed most preferred 
for critical embolization prevention. Thus, nominal model and new shunt orientation models were 
run using the 3.5mm shunt only. 
The problem is approached as a 2-phase flow including blood-to-particle interaction, while 
neglecting particle-to-particle interaction. Blood is handled with a Eulerian approach as a 
Newtonian fluid with constant density of 1060kg/m3 (Prather 34) under laminar flow conditions. 
Thrombi are modelled as solid spheres of set density of 1116.73kg/m3 (Prather 37) and varying 
size (1mm and 2mm). Note that densities were found from literature in previous studies of our lab 
groups, and set to maintain consistency for comparisons with previous findings. Particle sizes 
larger than 2mm were of no interest as embolization to the shunt itself would likely occur, being 
out of the scope of this paper. Particle-to-wall restitution coefficients were set for perfectly elastic 
collisions.  
The particles were tracked throughout the domain with a Lagrangian scheme, following 
the Lagrangian equation of motion, 
𝜕𝐿
𝜕𝑥𝑖
−
𝑑
𝑑𝑡
(
𝜕𝐿
𝜕?̇?𝑖
) = 0, 𝑖 = 1,2,3         ( 3 ) 
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where L is the Lagrangian equation, the difference between kinetic and potential energy, and x is 
a given coordinate. Lagrangian particle tracking is described as 
𝑑2𝑟
𝑑𝑡2
= ?⃑?(𝑣, 𝑢)           ( 4 ) 
where 𝑟 is the location of the particle, ?⃑? is the acceleration of the particle, ?⃑? is the velocity of the 
particle, and ?⃑⃑? is the velocity of the fluid. The total force experienced by the particle is 
∑ ?⃑?𝑏𝑜𝑑𝑦 + ∑ ?⃑?𝑠𝑢𝑟𝑓𝑎𝑐𝑒 = 𝑚𝑝
𝑑?⃑⃑?
𝑑𝑡
        ( 5 ) 
where 𝑚𝑝 is the mass of the particle. This was a Lagrangian scheme based on the Maxey-Riley 
equation to include fluid density, particle diameter, particle relaxation time, and fluid viscosity 
(Maxey and Riley 884). Gravity and drag forces are included as well as added-mass effect and 
Saffman lift, with the vessel geometry oriented in the standing position. Thus the forces are 
∑ ?⃑?𝑏𝑜𝑑𝑦 = ?⃑?𝑔𝑟𝑎𝑣𝑖𝑡𝑦          ( 6 ) 
∑ ?⃑?𝑠𝑢𝑟𝑓𝑎𝑐𝑒 = ?⃑?𝑑𝑟𝑎𝑔 + ?⃑?𝑎𝑑𝑑𝑒𝑑 𝑚𝑎𝑠𝑠 + ?⃑?𝑠𝑎𝑓𝑓𝑚𝑎𝑛      ( 7 ) 
The viscous fluid model was governed by the Navier-Stokes equations for incompressible 
fluid 
𝛻 ⋅ ?⃑⃑? = 0   and   𝛻 ⋅ 𝜏 − 𝛻𝑝 + 𝜌?⃑?𝑏𝑜𝑑𝑦 = 𝜌 (
𝜕?⃑⃑?
𝜕𝑡
+ (?⃑⃑? ⋅ 𝛻)?⃑⃑?)     ( 8 ) 
where τ is the viscous stress tensor, p is the pressure, and ρ is the density (Reddy 357). The physics 
continuum was modeled with Newtonian, turbulent flow with constant fluid density. The mesh 
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was finite volume with second order upwinding for convective derivatives. The mesh was 
developed as a prism layer with gap fill of 25% and element base size of 0.5mm, surface remesher, 
surface wrapper, and trimmer. The shunt and vessel wall surfaces were modeled as walls, while 
the pulmonary valve was modeled as a stagnation inlet. All other surfaces pertaining to the end of 
a vessel were modeled as mass flow inlets. 
 Each model must pass a grid independence study. As the three shunt orientation option 
models were developed from the beginning during this study, these models were tested by 
increasing and decreasing the element size by 5%. Normal element size was 0.5mm, while 
0.475mm was considered for a finer mesh and 0.525mm was considered for a coarser mesh. The 
change in cell count between meshes did not exceed 7.52%. The flow rates and pressures 
throughout the models were evaluated for constant applied pressure. Between the models, the 
change in flow were no greater than 0.02%, with changes in pressure even lesser. The models were 
therefore validated for grid independence. 
 
Figure 6: Option 1 Grid Independence Study 
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Figure 7: Option 2 Grid Independence Study 
 
Figure 8: Option 3 Grid Independence Study 
Due to the nature of flow in the shunt, three separate release locations are employed in the 
conduit: (1) proximal, (2) medial, and (3) distal to the RBTS-pulmonary root anastomosis. The 
initial velocity of these particles was set as 0m/s. Each particle released was counted with its 
specific size and release location, providing data on where particles are prone to travel based on 
release location. 
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Figure 9: Particle Injection Plane Location (1=Proximal, 2=Medial, 3=Distal) 
For purely statistical purposes, particle interactions are limited to particle-to-wall and 
particle-to-flow interactions. Particle velocities are plotted real time and particle counters are set 
at each boundary outlet to determine when and where particles leave the domain during several 
heart cycles. Each model was set to output approximately 300 particles of both diameters over 
three heart cycles. The models were run once to develop the flow field and particle presence, then 
run six times to collect data. The average and standard deviation was calculated from the results 
for each particle size and release location per model. 
Statistical significance was determined by the Chi-Square Test 
𝜒2 = ∑
(𝑂−𝐸)2
𝐸
           ( 9 ) 
where O is the observed data, and E is the expected data. A specific procedure was performed to 
determine the Chi-Square value of the resulting data sets. This test involves summing the rows and 
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columns for the given data set, and summing the sums of the rows and columns. Expected values 
are set for each data point by multiplying that data point’s column sum by its row sum, then 
dividing by the sum of the sums of the rows and sums of the columns. The Chi-Square calculation 
value for a specific data point is the observed value less the expected value squared, divided by 
the expected value. Once the Chi-Square calculation data is collected into a table relative to the 
original data set, the sum of the sums of the rows and the sums of the columns outputs the Chi-
Square value for the original data set. This value must exceed the values in the table below per the 
degrees of freedom and desired confidence level. 
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Table 1: Chi-Square Probabilities (Penn State) 
 
 See APPENDIX B for Chi-Square sample calculation. All data sets passed α of 0.005 at 
four degrees of freedom. The degrees of freedom were shunt diameter, particle diameter, particle 
release location, and exit boundary. 
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CHAPTER FIVE: STATISTICAL RESULTS AND DISCUSSION 
Three shunt sizes are investigated: 3mm, 3.5mm, and 4mm in diameter. Two different 
particle sizes are used in each case: 1mm and 2mm in diameter. The simulations were run for the 
duration of three heart cycles. Monitors tracked boundary exit of each particle with respect to its 
size and release location. Data tables were populated and averaged over all release locations. See 
APPENDIX B for complete data including variance. Note that the inlet boundary refers to the 
pulmonary valve. 
 
Figure 10: Boundary Nomenclature of Multiscale Model 
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Figure 11: Patient Specific, No Stenosis, 3.5mm RBTS Particle Tracking 
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Table 2: Embolization Rates for Various Shunt/Particle Size (Patient Specific, No Stenosis) 
 
 For the patient specific, no stenosis case, embolization rates are significantly high to the 
RCA across all shunt sizes. Embolization to the LCA is least for the 3.5mm RBTS and LcorA 
embolization is favorable over the 4mm RBTS. The coronary arteries experience higher 
embolization rates for 1mm particles over 2mm particles. A 2mm particle would have higher mass, 
and thus, a higher stokes number. It is reasonable to assume that a lower stokes number particle 
would be more likely to follow streamlines downward towards the coronary arteries instead of 
continuing in the direction of the shunt anastomosis as a heavier particle would. There is an inverse 
relationship between embolization rates to the RCA for 1mm and 2mm particles with increasing 
shunt diameter. As the shunt increases, 1mm particles decrease in embolization, while 2mm 
particles increase in embolization. The flow produced from a larger shunt must compete with flow 
entering the aortic arch from the pulmonary trunk. This mixture of flow separates particles of 
different mass, sending particles with lower Stokes number along the streamlines. There is likely 
a specific mass, or diameter in this case, of particle which does not change its embolization to the 
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RCA as a function of shunt diameter. What these results do show is that particles small enough to 
fit within the vessels surrounding the heart can take completely different paths based on their mass. 
The following table and figure display the critical embolization risks for the 0% stenosis 
case. 
Table 3: Critical Embolization Rates – 0% Stenosis 
 
 
Figure 12: Critical Embolization Rates – 0% Stenosis 
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40.00%
50.00%
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Embolization Rates - Shunt Options
Myocardial Infarction Stroke
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 Overall, the 0% stenosis case involves high embolization to the carotid arteries. The 3.5mm 
shunt reduces stroke risk, while maintaining low coronary embolization. In general, the rates do 
not vary significantly between the three shunt sizes, and there is an inverse relationship of stroke 
risk to myocardial infarction risk. 
Table 4: Embolization Rates for Various Shunt/Particle Size (Patient Specific, 90% Stenosis) 
 
 For the patient specific, 90% aortic arch stenosis, embolization rates are much higher for 
the coronary arteries. The carotid arteries along with the subclavian arteries experience less 
embolization to the no-stenosis case, while the inlet, or pulmonary valve showed higher 
embolization. For this case, the 3mm RBTS is most favorable for critical arteries, though the 
pulmonary valve experiences significant embolization. As the shunt is smaller, resistance is 
expected to be higher. Particles may not completely exit the shunt before retro flow occurs and 
pulls the particles towards the pulmonary valve. In this case of stenosis, embolization of 1mm and 
2mm particles increase embolization to the RCA with increasing shunt diameter. This is not the 
inverse relationship seen in the 0% stenosis case, and may be due to the lack of flow through the 
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aortic arch. The following table and figure display critical embolization rates for each shunt 
diameter in the 90% stenosis case. 
Table 5: Critical Embolization Rates – 90% Stenosis 
 
 
Figure 13: Critical Embolization Rates – 90% Stenosis 
The 90% stenosis case observes lower embolization to the carotid arteries than the case of 
no stenosis. Higher embolization to the coronaries is also a difference with stenosis. In general, 
with 90% stenosis, the 3mm shunt reduces critical embolization in both carotid and coronary 
arteries. 
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Between the two stenosis cases, the streamlines in the ascending aorta are quite different 
(see figure below). The 0% stenosis case shows smoother streamlines, while the 90% stenosis case 
displays more vortices. As the stenosis would constrict flow to evenly split from the shunt to the 
coronaries, carotids, and descending aorta, blood circulates within the ascending aorta and particles 
seem to exist in that space longer, lending to a higher probability of embolization to the coronaries. 
  
  
Figure 14: No Stenosis (Left) Vs. 90% Stenosis (Right) Streamlines in Ascending Aorta 
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 One important comparison to make between the two stenosis cases is the RCA 
embolization. In the 0% stenosis case, RCA embolization rates are significantly high. These drastic 
levels are not seen with 90% stenosis. When the aortic arch is constricted due to stenosis, a majority 
of flow to the common carotid and left carotid artery must come from the shunt. This causes higher 
flow rate in the shunt, and more distribution of particles to these arteries. When the aortic arch is 
free to provide flow, flow velocity is decreased in the shunt. This decrease in flow promotes a 
prothrombotic hemodynamic environment. Particles originating within the shunt are also forced 
into the common carotid artery from opposing aortic arch flow. Thus, a patient presenting with no 
aortic arch stenosis has a greater risk of embolization to the RCA fueled by two factors. Surgeons 
should be aware of this finding, as it can suggest that a patient with no aortic arch stenosis should 
not receive a RBTS unless absolutely necessary. 
Table 6: Embolization Rates for 3.5mm Shunt Size and Various Particle Size (Nominal, 90% Stenosis) 
 
 The 90% stenosis nominal model was run for the 3.5mm RBTS to compare findings from 
the 90% stenosis patient specific model. Trends in embolization to the coronary arteries and carotid 
arteries are consistent between the nominal and patient specific cases. However, large variation in 
data is shown in the pulmonary arteries and pulmonary valve. Variation itself supports the fact that 
this method must be applied to the specific geometry of the patient in question. Possible results 
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can be implied from similar geometry. But for the purpose of surgical planning, exact geometry 
should be used. Below displays the critical embolization risks for the nominal geometry. 
Table 7: Critical Embolization Rates – Nominal Geometry 
 
 
Figure 15: 90% Stenosis Nominal Geometry with Three Particle Injection Planes (In Green) 
 After obtaining the results from the no stenosis, 90% stenosis, and 90% stenosis nominal 
cases, three differing shunt orientations were modeled to attempt at reducing embolization rates to 
the carotid arteries. The three attempts were to increase angle of anastomosis at the innominate 
artery, move the shunt out of plane to have an outlet normal in line with the aortic arch, and to 
move the anastomosis proximal on the ascending aorta. The shunt diameter was held constant at 
3.5mm between the three options. The generated models are as follows. 
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Figure 16: New Shunt Geometries Including Option 1 (Top), Option 2 (Middle), and Option 3 (Bottom) 
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Table 8: Embolization Rates for 3.5mmBT Shunt and Various Particle Size and Geometry Option (Patient Specific, 
No Stenosis) 
 
 The results for all three options are indicative that shunt placement is critical in surgical 
planning. Option 1 presents benefits in embolization rates to the right carotid artery over the 
original geometry. The increased angle of anastomosis was successful in directing particles away 
from the right carotid artery. However, the right subclavian artery experienced more embolization. 
The increased angle of anastomosis causes the flow to impact directly into the innominate artery 
wall and create a highly vorticial environment. This would cause particles to change direction and 
move towards the common carotid artery. This option was initially intended to point particle flow 
away from the right carotid artery, and it did just that. However, the flow of particles still exists in 
the common carotid artery, though directed towards a less life threatening path. The left carotid 
artery suffered more embolization, which would be expected if particles would be diverted from 
the right carotid artery and move towards the aortic arch. This effect is seen in all three options, 
but option 2 and 3 show significant right carotid artery embolization prevention, with option 3 at 
the greatest. Most particles in these last two options are in the end diverted towards the pulmonary 
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arteries and descending aorta. Embolization rates to the coronaries increase substantially from the 
original geometry in all cases. Option 3 presents a major coronary embolization issue. This is 
understandable for option 3 as the outlet of the shunt is closer to the coronary arteries. As 
mentioned before, option 3 decreases embolization to the RCA significantly. This is likely due to 
how the particles behave when first injected. Starting at a velocity of 0m/s, the particles take time 
to accelerate and follow the streamlines, with heavier particles increasing that time. Since the shunt 
in option 3 is sutured so far away from the RCA, particles seem to accelerate with enough time to 
follow the flow field away from the RCA. Additionally, in a practical setting, a shunt of such short 
length would reduce chances of thrombosis as there is less blood-to-foreign surface contact. One 
should note that the patient specific model is in fact specific to the patient. Other patient geometries 
may not be as suitable for any one of these three shunt placements. Additionally, in many cases, 
ascending aortic atresia can reduce the surface area available for suturing the RBTS. If the 
ascending aorta is small enough, option 3 may not even be possible. The following table and graph 
display the associated risks of stroke or myocardial infarction between the three shunt placement 
options. 
Table 9: Critical Embolization Rates – Shunt Placement Options 
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Figure 17: Critical Embolization Rates – Shunt Placement Options 
 In general, option 3 reduces stroke risk significantly. However, myocardial infarction risk 
is approximately three times higher when compared to the other two options. Option 2 reduces 
carotid artery embolization significantly while reducing coronary embolization to the lowest rate 
among the three options. 
The results shown above for varying shunt size and placement prove that surgical planning 
can benefit from patient specific CFD models. Depending on the patient geometry, a specific shunt 
diameter and placement can be chosen to minimize stroke or myocardial infarction risk. As seen 
in this case, a 3.5mm RBTS in placement option 2 reduces stroke risk while managing coronary 
embolism, and is still possible in the case of severe ascending aortic atresia. 
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CHAPTER SIX: FUTURE WORK 
 In every model employed in this study, particles are randomly released at arbitrary times 
during the heart cycle. In reality, a thrombus may require a specific amount of shear to separate 
from the shunt wall, occurring during systole and not during diastole. As such, newer models may 
track particle release time and create statistics based on time release. The results may reveal 
interesting trends in embolization rates. Alternatively, if data were collected on hemodynamic 
conditions required to separate thrombi from the shunt wall, the simulation could incorporate such 
a range of values to only release a particle when a specific point is experiencing pressure above 
the threshold. 
 The particles in this study were modeled as simple spheres with a coefficient of restitution 
of 1 for particle-to-wall interaction. These are simply not the true characteristics of thrombi, as 
their makeup is gelatinous and deformable. Further studies must be done to quantify the physical 
properties of thrombi as they relate to restitution and shape. Incorporating such data into the models 
used in this paper may provide more realistic results. 
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CHAPTER SEVEN: CONCLUSION 
This study presents CFD as a viable and effective tool in determining surgical plans. In the 
patient geometry of this study, an optimal shunt size of 3.5mm in diameter could be determined 
for reducing cerebral thromboembolization in the zero-stenosis case, while the 90% stenosis case 
requires a 3mm shunt size. In both stenosis cases, the 3mm shunt reduces embolization to the 
coronaries. A shunt with increased angle of anastomosis reduced embolization to the right 
coronary artery, however other critical arteries suffered higher embolization. A shunt in plane with 
the aortic arch reduced embolization to the right carotid artery, while maintaining low 
embolization to the left carotid and coronary arteries. A shunt with anastomosis proximal to the 
innominate artery prevents common carotid embolization in general, though it increases coronary 
embolization significantly. These results suggest, in general, 3-3.5mm shunts at shorter lengths 
with anastomosis proximal to the innominate artery seem to be best practice in the Hybrid 
Norwood procedure. In the case of ascending aortic atresia, a 3-3.5mm shunt in plane with the 
aortic arch would still minimize potential life threatening embolization. A RBTS may even be 
determined to be a dangerous option for stage I palliation for a patient presenting with minimal 
aortic arch stenosis. In summary, a surgeon can utilize this method to numerically justify a surgical 
plan for reducing stroke incidence or myocardial infarction given the geometry of the patient of 
concern. Every decision made by the surgeon can have severe consequences, so it is paramount 
that as much information as possible is at his or her disposal. As the Hybrid Norwood procedure 
is used often in HLHS, understanding embolization rates associated with the RBTS geometry of 
concern will better equip physicians to administer this life changing procedure and ensure higher 
success rates. 
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APPENDIX A: DA PRESSURE PLOT
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Figure 18: Pressure Plot of Descending Aorta Boundary During One Heart Cycle 
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APPENDIX B: IN-DEPTH STATISTICAL ANALYSIS
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Table 10: Embolization Rates for Various Shunt/Particle Size (Patient Specific, No Stenosis) Including Variance 
 
Table 11: Embolization Rates for Various Shunt/Particle Size (Patient Specific, 90% Stenosis) Including Variance 
 
Table 12: Embolization Rates for 3.5mm Shunt Size and Various Particle Size (Nominal, 90% Stenosis) Including 
Variance 
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Table 13: Embolization Rates for 3.5mmBT Shunt and Various Particle Size and Geometry Option (Patient Specific, 
No Stenosis) Including Variance 
 
Table 14: Chi-Square Calculation Table Example (Patient Specific, No Stenosis) 
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